|
|
Volumn 46, Issue 6, 2000, Pages 338-343
|
|
Age, sex, haemoglobin level, and white cell count at diagnosis are important prognostic factors in children with acute lymphoblastic leukemia treated with BFM-type protocol
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILEUKEMIC AGENT;
ASPARAGINASE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DOXORUBICIN;
HEMOGLOBIN;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISOLONE;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
AGE;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RISK;
CANCER SURVIVAL;
CENTRAL NERVOUS SYSTEM TUMOR;
CHILD;
CHILDHOOD DISEASE;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
DIAGNOSTIC PROCEDURE;
FEMALE;
HEMOGLOBIN DETERMINATION;
HUMAN;
INFANT;
LEUKOCYTE COUNT;
LIVER SIZE;
LYMPHADENOPATHY;
MAJOR CLINICAL STUDY;
MALAYSIA;
MALE;
MEDIASTINUM MASS;
MULTIVARIATE ANALYSIS;
PROGNOSIS;
RACE DIFFERENCE;
RECURRENCE RISK;
RISK ASSESSMENT;
SEX DIFFERENCE;
SPLEEN SIZE;
THROMBOCYTE COUNT;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TREATMENT PLANNING;
UNIVERSITY HOSPITAL;
AGE FACTORS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
CHILD, PRESCHOOL;
CLINICAL PROTOCOLS;
FEMALE;
HEMOGLOBINS;
HUMANS;
INFANT;
LEUKEMIA, LYMPHOCYTIC, ACUTE;
LEUKOCYTE COUNT;
MALE;
MULTIVARIATE ANALYSIS;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RETROSPECTIVE STUDIES;
RISK FACTORS;
SEX FACTORS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 0034502508
PISSN: 01426338
EISSN: None
Source Type: Journal
DOI: 10.1093/tropej/46.6.338 Document Type: Article |
|
Times cited : (15)
|
|
References (28)
|
